Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycerol + electrolyte solution is an intravenous osmotic dehydrating agent primarily used to reduce intracranial pressure (ICP) and intraocular pressure (IOP). The glycerol component increases plasma osmolality, creating an osmotic gradient that draws water from the extravascular space—such as brain parenchyma or aqueous humor—into the intravascular space. The inclusion of electrolytes, typically sodium chloride, serves to maintain systemic osmotic balance and prevent the electrolyte imbalances that can occur with pure osmotic diuresis. This combination is frequently utilized in the management of cerebral edema associated with stroke, trauma, or neurosurgery, as well as in the emergency treatment of acute glaucoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerol + electrolyte solution.